Intraventricular colistin in Gram-negative ventriculoperitoneal shunt infection in two pediatric patients

Acta Neurochirurgica

Volumn 157, Issue 12, 2015, Pages 2219-2220

  Santos, Ana Sofia ^a,b   Iraneta, Amets ^a   Matos, Mário ^a   Brito, Maria Joao ^a  

^a HOSPITAL DONA ESTEFÂNIA   (Portugal)

^b Serviço Doenças Infecciosas CHSJ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTICONVULSIVE AGENT; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICULITIS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CHILD; CHILDHOOD DISEASE; ENZYME ISOLATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FOLLOW UP; GROUP B STREPTOCOCCAL MENINGITIS; HEART VALVE REPLACEMENT; HOSPITAL DISCHARGE; HUMAN; HYDROCEPHALUS; INFANT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MALE; MENINGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE; SHUNT INFECTION; SINGLE DRUG DOSE; SURGICAL PATIENT; TREATMENT DURATION;

EID: 84947128549     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-015-2588-0     Document Type: Letter

References (6)

1. Antachopoulos C, Karvanen G, Leone M, Broggi G (2010) Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agent Chemother 54:3985–87
2. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M, David A (2010) Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 14:e572–e579
3. Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistance Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agent 41:499–508
4. Markantonis SL, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I, Dimopoulou E, Baltopoulos G (2009) Penetration of colistin into cerebrospinal fluid. Antimicrob Agent Chemother 53:4907–10
5. Michalopoulos A, Falagas M (2011) Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensiv Care 1:30
6. Tunkel A, Hartman B, Kaplan S, Kaufman B, Roos K, Scheld M, Whitley R (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–84